Health & Life Sciences

Overview

As a stakeholder in the health and life sciences industry, you work every day to extend the boundaries of human health and enhance patient care. Our national health and life sciences industry team partners with you to advance your objectives in a complex and heavily regulated environment. Whether collaborating with a pharmaceutical company to guide a new drug through the product development life cycle or helping health care providers implement compliance programs, we provide business-minded strategies and legal solutions to navigate your most pressing challenges. We have completed major health care transactions, represented health providers in high-stakes litigation, and executed public policy and government affairs strategies for research institutions and patient advocacy organizations. Our professionals have served as in-house counsel for health systems and global pharmaceutical and device companies, health policy specialists at the congressional and agency level, and counsel at the Department of Justice (DOJ) and the Food and Drug Administration (FDA).

Health & Life Sciences

Overview

DOJ and Partners Continue Fight Against Illegal Online Drug Sellers

Opioid Epidemic Policies Must Be Geared Toward Protecting Children

‘Text Me Your Symptoms’: CMS Proposes Expanding Coverage for Digital Health Services

‘Text Me Your Symptoms’: CMS Proposes Expanding Coverage for Digital Health Services

George Mesires Discusses Legal Market Trends with Senior Housing Business

Telemedicine on the Rise: Five Factors Driving Telehealth Growth in 2017 – and Beyond

Staking Original Claim, New Jersey Incorporates Daubert Factors

Steve Lokensgard Provides Insight to Bloomberg On Medicare Payments

Fraudulent Misjoinder in Drug and Device Litigation

Medicaid's Unnecessary Barriers Delay Care for Children With Complex Needs

Libby Baney Discusses Instagram's Decision to Ban Drug Hashtags with Digital Trends

Libby Baney Discusses Opioids on Instagram with CNN

CRISPR Technology: Broad Institute of MIT and Harvard Wins Pivotal Patent Battle on Appeal

Staking Original Claim, New Jersey Incorporates Daubert Factors

Brand-Name Manufacturers Could Be Liable for Generic Drug Injuries, Says Massachusetts Supreme Court

CRISPR Technology: Broad Institute of MIT and Harvard Wins Pivotal Patent Battle on Appeal

Tricia Beckmann Shares Comments About Health Care Enrollment With Inside Health Policy

Libby Baney Explains the Importance of Telemedicine with Politico

Insights & Events

From Approval to Coverage – FDA and CMS Jurisdiction Lines

Premier's National Meeting for the Bundled Payment & Population Health Management Collaboratives - Washington, DC

Innovator Liability for Drug Manufacturers

Related Services and Industries

Experience

Our Experience